Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Biswal S, Mendez Galvan JF, Macias Parra M, Galan-Herrera JF, Carrascal Rodriguez MB, Rodriguez Bueno EP, Brose M, Rauscher M, LeFevre I, Wallace D, Borkowski A. Biswal S, et al. Among authors: macias parra m. Rev Panam Salud Publica. 2021 Jun 11;45:e67. doi: 10.26633/RPSP.2021.67. eCollection 2021. Rev Panam Salud Publica. 2021. PMID: 34131423 Free PMC article.
Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants.
Macías-Parra M, Vidal-Vázquez P, Reyna-Figueroa J, Rodríguez-Weber MÁ, Moreno-Macías H, Hernández-Benavides I, Fortes-Gutiérrez S, Richardson VL, Vázquez-Cárdenas P. Macías-Parra M, et al. Front Public Health. 2024 Feb 23;12:1356932. doi: 10.3389/fpubh.2024.1356932. eCollection 2024. Front Public Health. 2024. PMID: 38463163 Free PMC article. Clinical Trial.
Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls: Three-year Follow-up of a Randomized Phase III Trial.
Lin L, Macias Parra M, Sierra VY, Salas Cespedes A, Granados MA, Luque A, Karkada N, Castrejon Alba MM, Romano-Mazzotti L, Borys D, Struyf F. Lin L, et al. Among authors: macias parra m. Pediatr Infect Dis J. 2019 Oct;38(10):1061-1067. doi: 10.1097/INF.0000000000002437. Pediatr Infect Dis J. 2019. PMID: 31469776 Clinical Trial.
Antimicrobial resistance and antibiotic consumption in Mexican hospitals.
Miranda-Novales MG, Flores-Moreno K, López-Vidal Y, Rodríguez-Álvarez M, Solórzano-Santos F, Soto-Hernández JL, Ponce de León-Rosales S; UNCAR Network*. Miranda-Novales MG, et al. Salud Publica Mex. 2020 Jan-Feb;62(1):42-49. doi: 10.21149/10543. Salud Publica Mex. 2020. PMID: 31869560 English.
Economic burden of varicella complications in two referral centers in Mexico.
Macias-Parra M, Rodriguez-Weber MA, Moreno-Espinosa S, Ceron-Trujillo B, Ojeda-Diezbarroso K, DeAntonio R, Cortes-Alcala R, Martinez G, Carreño-Manjarrez R, Jiménez-Juárez RN. Macias-Parra M, et al. Hum Vaccin Immunother. 2018;14(12):2950-2954. doi: 10.1080/21645515.2018.1504541. Epub 2018 Oct 23. Hum Vaccin Immunother. 2018. PMID: 30156953 Free PMC article.
Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City.
Macias-Parra M, Fortes-Gutierrez S, Aguilar-Gomez N, Diaz-Garcia L, Otero-Mendoza F, Arias de la Garza E, Ordoñez-Ortega J, Palacios-Reyes D, Diaz-Jimenez IV, Serrano-Sierra A, Xochihua-Díaz L, Saltigeral-Simental P. Macias-Parra M, et al. J Trop Pediatr. 2021 Jul 2;67(3):fmab025. doi: 10.1093/tropej/fmab025. J Trop Pediatr. 2021. PMID: 34213541
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group. Ruiz-Palacios GM, et al. Among authors: macias parra m. N Engl J Med. 2006 Jan 5;354(1):11-22. doi: 10.1056/NEJMoa052434. N Engl J Med. 2006. PMID: 16394298 Free article. Clinical Trial.
28 results